NCT06622044 Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
| NCT ID | NCT06622044 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eye & ENT Hospital of Fudan University |
| Condition | Esotropia |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-09-07 |
| Primary Completion | 2026-09-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-09-07 with a primary completion date of 2026-09-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, single-center, nonrandomized comparative study evaluates 6-month ocular alignment and binocular visual function outcomes following combined accommodation and fusional training or prism correction in patients with small-angle acute acquired comitant esotropia. Treatment was selected through shared decision-making between the patient and the treating clinician according to the clinical presentation and patient preference.
Eligibility Criteria
Inclusion Criteria: 1. Aged 10-40 years (including 10 years and 40 years); 2. Best-corrected visual acuity no worse than 20/20 for both eyes; 3. Deviation angle less than 15 prism diopters (including 15 prism diopters); Exclusion Criteria: 1. Organic eye diseases; 2. Lesions of the brain; 3. Receiving esotropia therapy(including surgery and prism treatment) 4. Devation angle reducing more than 10 prism diopters after refractive correction
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06622044 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 40 Years, studying Esotropia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06622044 currently recruiting?
Yes, NCT06622044 is actively recruiting participants. Contact the research team at wenweneye@126.com for enrollment information.
Where is the NCT06622044 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06622044 clinical trial?
NCT06622044 is sponsored by Eye & ENT Hospital of Fudan University. The trial plans to enroll 100 participants.